Mesoblast Limited announced that effective August 30, 2021, post-release of the financial results, Chief Financial Officer (CFO) Josh Muntner will be leaving the organization and Andrew Chaponnel will assume the role of interim CFO. Prior to his departure, Mr. Muntner will work closely with the Board and management team to coordinate finalization of the FY21 financial statements and effect an orderly transition. Andrew Chaponnel will be appointed interim CFO effective August 30, 2021. Mr. Chaponnel has demonstrated strong leadership skills over the past nine years at Mesoblast, initially as Group Financial Controller and for the past three years as Head of Finance. Throughout this period he has been an integral member of the senior management team on various corporate transactions and has provided exemplary oversight of the finance functions.